Ozempic Shot Duration: Pharmacokinetics and Clinical Evidence

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Ozempic (semaglutide) has an approximate half-life of seven days, meaning roughly half the injected dose is eliminated from your body each week. This pharmacokinetic profile enables once-weekly subcutaneous dosing and supports predictable steady-state accumulation over the first four to five weeks of treatment initiation or dose escalation.

Understanding how long semaglutide persists in circulation matters because it shapes dosing intervals, onset of effects, and washout periods if treatment is discontinued. For patients considering GLP-1 therapy, this knowledge supports informed discussions with providers about realistic timelines for symptom changes and the importance of adherence to scheduled injections.

Semaglutide Pharmacokinetics: Half-Life and Steady-State Accumulation

Semaglutide reaches maximum serum concentration approximately 24 to 48 hours after subcutaneous injection. The drug's seven-day half-life means that after one week, approximately 50% of the injected dose remains active in your bloodstream. After two weeks (two half-lives), about 25% persists; after three weeks, roughly 12.5% remains active.

Steady-state concentration develops after approximately four to five weeks of consistent weekly dosing. At steady state, the amount of drug entering your body each week equals the amount being eliminated, resulting in stable plasma levels. This accumulation pattern is why providers typically recommend waiting four to five weeks between dose escalations to accurately assess treatment response.

Semaglutide Duration Across Dose Escalation and Individual Variation

Individual factors influence how long semaglutide remains active and effective. Body composition, renal and hepatic function, metabolic rate, and genetic variation in GLP-1 receptor expression can affect drug clearance and clinical response timing. These variations explain why some patients notice appetite suppression within days of injection while others require two to three weeks.

The table below summarizes key pharmacokinetic parameters and factors that influence semaglutide persistence and clinical effect duration, helping contextualize why dosing schedules and treatment responses vary among individuals.

Parameter	Details
Half-Life	Approximately 7 days in serum
Time to Peak Concentration	24–48 hours post-injection
Steady-State Timeline	4–5 weeks of consistent weekly dosing
Primary Elimination Route	Proteolytic degradation; minor renal excretion
Factors Affecting Duration	Body weight, renal/hepatic function, genetic GLP1R variants
Recommended Dose Interval	Once weekly (same day each week)
Washout Period After Discontinuation	Approximately 4–5 weeks for near-complete elimination

Clinical Implications of Semaglutide's Seven-Day Half-Life

The once-weekly injection schedule aligns with semaglutide's seven-day half-life, maintaining therapeutic levels without daily administration burden. This dosing pattern also simplifies adherence tracking and reduces injection-related anxiety for many patients. However, consistency matters: missing a dose or injecting significantly late extends the interval below therapeutic concentration.

When transitioning between doses or discontinuing treatment, the seven-day half-life means clinically relevant amounts persist for three to four weeks after the final injection. Patients should not expect immediate appetite restoration or weight regain upon stopping; gradual rebound occurs over this washout period. Providers may space dose increases by 7–14 days to allow steady-state assessment between escalations.

Genetic and Biomarker Factors Influencing Individual Drug Duration

Variation in GLP-1 receptor (GLP1R) expression, influenced partly by genetic polymorphisms, can affect how long semaglutide's clinical effects persist. Individuals with genetic predispositions favoring robust GLP-1 receptor activity may experience more pronounced appetite suppression and earlier symptom onset, while those with reduced receptor sensitivity may require longer observation periods or higher doses to achieve therapeutic benefit.

Metabolic biomarkers—including fasting glucose, insulin levels, and body composition—also influence drug clearance and clinical duration. Individuals with insulin resistance or elevated hepatic burden may clear semaglutide differently, potentially extending or shortening perceived drug duration. These factors underscore why personalized assessment before and during treatment supports optimal dosing and expectation-setting.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test examines predispositions in GLP-1 receptor signaling pathways—specifically variants like —that may help provide context for how your body responds to semaglutide's duration and intensity. Individuals with genetic patterns favoring enhanced GLP-1 signaling may experience clinical effects more prominently during semaglutide's seven-day circulation window, while those with different predispositions may benefit from longer observation periods or dose adjustments.

The genetic test reveals predispositions in peptide pathway activation, not exact medication response. This information should be interpreted with a qualified healthcare provider to inform discussions around expected onset timing, dose tolerability, and the clinical significance of semaglutide's pharmacokinetic profile for your specific genetic background.

Understanding your genetic predispositions in GLP-1 receptor function, combined with semaglutide's known seven-day half-life, can support a more informed conversation with your provider about realistic timelines for symptom changes, optimal dosing frequency, and whether compounded semaglutide or alternative GLP-1 compounds may align better with your individual pharmacokinetic profile.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose GLP-1 Protocol is $129/mo flat. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What does the article's table give as semaglutide's time to peak concentration after an injection?

The article's table lists 24 to 48 hours post-injection as the time to peak serum concentration. That sits alongside its stated half-life of roughly seven days and a steady-state timeline of four to five weeks of consistent weekly dosing. The post uses these figures to explain why the once-weekly schedule works and why effects are not immediate after a single injection.

How much semaglutide does the post say remains in circulation after two and three weeks?

The article applies the seven-day half-life directly: about 50 percent of an injected dose remains after one week, roughly 25 percent after two weeks, and about 12.5 percent after three weeks. It uses this decay pattern to explain why the drug accumulates toward steady state over the first four to five weeks and why levels do not disappear the moment treatment ends.

What washout period does the article's table give after a final injection?

The table lists approximately four to five weeks for near-complete elimination after discontinuation. Elsewhere the same article says clinically relevant amounts persist for three to four weeks after a final injection, so the two figures do not fully agree. Either way, the post's point is that appetite does not rebound immediately and any regain happens gradually across that window.

Which elimination route does the post name as primary for semaglutide?

The article's table names proteolytic degradation as the primary elimination route, with minor renal excretion. It lists body weight along with renal and hepatic function among the factors affecting how long the drug persists. The post uses this to explain why clearance and perceived duration can differ between individuals who are on exactly the same weekly schedule.

Why does the article say four to five weeks matters when judging whether treatment is working?

Because that is when steady state develops: the amount of drug entering the body each week equals the amount eliminated, so plasma levels stabilise. The article says providers typically wait that long between escalations in order to assess response accurately. It also notes some people feel appetite changes within days while others take two to three weeks, which is a separate question.

Related Reading

• Ozempic Shot
• Do Genetics Affect How Long My Reproductive Years Will Last
• Lifemd Ozempic
• Eden Ozempic

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.